Compare NPFD & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NPFD | NBY |
|---|---|---|
| Founded | 2021 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.6M | 398.2M |
| IPO Year | N/A | 2007 |
| Metric | NPFD | NBY |
|---|---|---|
| Price | $19.56 | $0.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 64.7K | ★ 1.9M |
| Earning Date | 01-01-0001 | 04-01-2026 |
| Dividend Yield | ★ 6.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | ★ $10,302,000.00 |
| Revenue This Year | N/A | $23.91 |
| Revenue Next Year | N/A | $32.05 |
| P/E Ratio | ★ N/A | $23.40 |
| Revenue Growth | N/A | ★ 390.34 |
| 52 Week Low | $14.50 | $0.46 |
| 52 Week High | $18.07 | $19.95 |
| Indicator | NPFD | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 49.02 | 35.04 |
| Support Level | $19.60 | $0.57 |
| Resistance Level | $19.93 | $0.72 |
| Average True Range (ATR) | 0.16 | 0.32 |
| MACD | 0.01 | -0.21 |
| Stochastic Oscillator | 37.77 | 1.54 |
Nuveen Variable Rate Preferred&Income is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The fund invests a majority of its assets in variable-rate preferred securities and other variable-rate income-producing securities. The rest of its investments can be made in contingent capital securities or contingent convertible securities, convertible securities, corporate debt securities, U.S. government securities, residential and commercial mortgage-backed securities, fixed-rate preferred securities, senior loans and loan participations and assignments, sovereign debt instruments, debt securities issued by supranational agencies, and/or taxable and tax-exempt municipal bonds.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.